CRSP announces their gene editing treatment in a remarkable study ostensibly cures patient of sickle cell anemia
by Social_History In a remarkable result, CRSP shows that their gene editing treatment, using the CRISPR-Cas9 technology that recently won its co-founder Emmanuelle Charpentier the 2020 Nobel Prize in chemistry, effectively cured one patient of sickle cell anemia and another of B-thalassemia. CRSP announces these results in a talk at the American Society of Hematologists … Read more